Open Accessibility Menu

Pharmacy Enterprise 340B Drug Pricing Divison

The 340B Program requires pharmaceutical manufacturers to extend upfront discounts on covered outpatient medications purchased by federally registered covered entities. Congress passed the 340B Program as part of the Veterans Health Care Act in November of 1992. The program’s intent was to aid safety-net providers whom serve the nation’s most vulnerable patient populations in “stretching scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” Pharmaceutical discounts extended to covered entities range anywhere from 15 to 60 percent. RWJBarnabas Health (RWJBH) has been able to transform these savings into increased access to care and medication for eligible patients in underserved communities with the greatest need.

The RWJBH 340B Program began with a single hospital over 10 years ago. The health system has since expanded into nine different covered entities registered with the Health Resources & Services Administration (HRSA). RWJBH’s 340B program is comprised of seven disproportionate share hospitals (DSH), one children’s hospital, and one hemophilia treatment center. Each covered entity has contracted pharmacy agreements with a local retail network, including RWJBH wholly owned retail and specialty pharmacies. These arrangements further increase access to affordable medications for our eligible patients.

The RWJBH pharmacy enterprise has a central role in the initiation, operations, compliance and auditing of this complex program. This requires a coordinated effort between local facilities and the corporate pharmacy 340B team with the support of our 340B software vendor. The 340B team ensures RWJBH covered entities provide all required data to essential external vendors and routinely conduct data integrity reviews to maintain accuracy and compliance.

RWJBH facilities participating in the 340B Program are subject to audit by drug manufacturers, HRSA, and internal audit from the Corporate 340B Division. Failure to comply with 340B Program requirements could result in refund of discounts back to a manufacturer(s) or potential expulsion from the program.

During 2023, the corporate pharmacy 340B team assisted Children’s Specialized Hospital with its enrollment into the 340B Program. Additionally, the team assisted with the successful transition of 5 DSH facilities from Cerner Millennium to EPIC, with little to no financial impact, as part of the RWJBH EPIC Together project. The team’s efforts, executed with limited resources, helped to ensure compliant 340B Program utilization. Through continuous evaluation of 340B Program operations, the team has continued to increase efficiencies and maximize program benefits for the RWJBarnabas Health System.

Pharmacy Enterprise 340B Drug Pricing Divison Leadership